BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

CAPS Rating: 2 out of 5

A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.


Player Avatar manirg (67.47) Submitted: 3/9/2014 10:28:55 PM : Outperform Start Price: $9.03 BDSI Score: +35.56

Undervalued. FDA approved drug and more coming. Proven delivery
system. A 5-10x potential.

Featured Broker Partners